These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 11753231)
21. Tumour biology and histopathology of neuroendocrine tumours. Klöppel G Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263 [TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine tumors of the gastrointestinal tract]. Klöppel G Pathologe; 2003 Jul; 24(4):287-96. PubMed ID: 14513276 [TBL] [Abstract][Full Text] [Related]
24. Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors. Rindi G; Capella C; Solcia E J Mol Med (Berl); 1998 May; 76(6):413-20. PubMed ID: 9625298 [TBL] [Abstract][Full Text] [Related]
25. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Klöppel G; Perren A; Heitz PU Ann N Y Acad Sci; 2004 Apr; 1014():13-27. PubMed ID: 15153416 [TBL] [Abstract][Full Text] [Related]
26. Classification of neuroendocrine tumors. Klöppel G Verh Dtsch Ges Pathol; 1997; 81():111-7. PubMed ID: 9474861 [TBL] [Abstract][Full Text] [Related]
27. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808 [TBL] [Abstract][Full Text] [Related]
28. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment]. Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402 [No Abstract] [Full Text] [Related]
29. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Ardill JE; O'Dorisio TM Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544 [TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms]. Zhu XZ Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561 [TBL] [Abstract][Full Text] [Related]
34. Preface: Gastroenteropancreatic system and its tumors: Part 1. Vinik AI Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xvii-xviii. PubMed ID: 21095538 [No Abstract] [Full Text] [Related]
35. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS Virchows Arch; 2010 Jun; 456(6):595-7. PubMed ID: 20422210 [No Abstract] [Full Text] [Related]
36. Endocrine tumors of the pancreas. Simon P; Spilcke-Liss E; Wallaschofski H Endocrinol Metab Clin North Am; 2006 Jun; 35(2):431-47, xii. PubMed ID: 16632104 [TBL] [Abstract][Full Text] [Related]
37. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Chetty R Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027 [TBL] [Abstract][Full Text] [Related]
38. [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies]. Bergmann F Pathologe; 2013 Nov; 34 Suppl 2():221-5. PubMed ID: 24196617 [TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumour management: a team approach. Banfield A; Green S; Ramage JK Hosp Med; 2005 Jan; 66(1):37-42. PubMed ID: 15686165 [TBL] [Abstract][Full Text] [Related]